Browse > Article
http://dx.doi.org/10.4174/astr.2018.95.5.267

Clinical outcome of 1,000 consecutive cases of liver transplantation: a single center experience  

Kwak, Bong Jun (Department of Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea)
Kim, Dong Goo (Department of Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea)
Han, Jae Hyun (Department of Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea)
Choi, Ho Joong (Department of Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea)
Bae, Si Hyun (Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea)
You, Young Kyoung (Department of Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea)
Choi, Jong Young (Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea)
Yoon, Seung Kew (Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea)
Publication Information
Annals of Surgical Treatment and Research / v.95, no.5, 2018 , pp. 267-277 More about this Journal
Abstract
Purpose: The aim of this study was to analyze survival outcomes in 1,000 consecutive liver transplantations (LTs) performed at a single institution from 1993 to April 2017. Methods: The study population was divided into 2 groups based on donor type: deceased donor LT (DDLT; n = 181, 18.1%) and living donor LT (LDLT; n = 819; 81.9%), and into 3 periods based on the number of cases (first 300 cases, middle 300 cases, last 400 cases). Results: Infection was the most common cause of death, accounting for 34.8% (95 of 273). Mortality due to hepatocellular carcinoma recurrence occurred most frequently between 1 and 5 years after transplantation. Mortality rate by graft rejection was highest between 5 and 10 years after transplantation. And mortality by de novo malignancy occurred most frequently after 10 years after transplantation. The patient survival rates for the entire population at 5 and 10 years were 74.7%, and 68.6%, respectively. There was no difference in survival rate between the LDLT and DDLT groups (P = 0.188). Cause of disease, disease severity, case period, and retransplantation had a significant association with patient survival (P = 0.002, P = 0.031, P = 0.003, and P = 0.024, respectively). Conclusion: Surgical techniques and perioperative management for transplant patients have improved and undergone standardization. Controlling perioperative infection and managing patients with HCC as LT candidates will result in better outcomes.
Keywords
Liver transplantation; Cause of death; Survival; Risk factors;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Tamura S, Sugawara Y, Kokudo N. Section 4. Further expanding the criteria for HCC in living donor liver transplantation: the Tokyo University experience. Transplantation 2014;97 Suppl 8:S17-20.   DOI
2 Yao FY. Liver transplantation for hepatocellular carcinoma: beyond the Milan criteria. Am J Transplant 2008;8:1982-9.   DOI
3 Markowitz JS, Martin P, Conrad AJ, Markmann JF, Seu P, Yersiz H, et al. Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin. Hepatology 1998;28:585-9.   DOI
4 Todo S, Furukawa H; Japanese Study Group on Organ Transplantation. Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan. Ann Surg 2004;240:451-9.   DOI
5 Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693-9.   DOI
6 Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001;33:1394-403.   DOI
7 Decaens T, Roudot-Thoraval F, Hadni-Bresson S, Meyer C, Gugenheim J, Durand F, et al. Impact of UCSF criteria according to pre- and post-OLT tumor features: analysis of 479 patients listed for HCC with a short waiting time. Liver Transpl 2006;12:1761-9.   DOI
8 Freeman RB, Harper A, Edwards EB. Excellent liver transplant survival rates under the MELD/PELD system. Transplant Proc 2005;37:585-8.   DOI
9 Rana A, Hardy MA, Halazun KJ, Woodland DC, Ratner LE, Samstein B, et al. Survival outcomes following liver transplantation (SOFT) score: a novel method to predict patient survival following liver transplantation. Am J Transplant 2008;8:2537-46.   DOI
10 Cholongitas E, Marelli L, Shusang V, Senzolo M, Rolles K, Patch D, et al. A systematic review of the performance of the model for end-stage liver disease (MELD) in the setting of liver transplantation. Liver Transpl 2006;12:1049-61.   DOI
11 Yi NJ, Suh KS, Suh SW, Chang YR, Hong G, Yoo T, et al. Excellent outcome in 238 consecutive living donor liver transplantations using the right liver graft in a large volume single center. World J Surg 2013;37:1419-29.   DOI
12 Strong RW, Lynch SV, Ong TH, Matsunami H, Koido Y, Balderson GA. Successful liver transplantation from a living donor to her son. N Engl J Med 1990;322:1505-7.   DOI
13 Iwatsuki S, Shaw BW, Starzl TE. Fiveyear survival after liver transplantation. Transplant Proc 1985;17:259-63.
14 Berg CL, Steffick DE, Edwards EB, Heimbach JK, Magee JC, Washburn WK, et al. Liver and intestine transplantation in the United States 1998-2007. Am J Transplant 2009;9(4 Pt 2):907-31.   DOI
15 Tzakis A, Todo S, Starzl TE. Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg 1989;210:649-52.   DOI
16 Korea Centers for Disease Control & Prevention. 2016 Konos Annual Report [Internet]. Seoul (Korea): Korea Centers for Disease Control & Prevention, Korean Network for Organ Sharing; c2014 [cited 2017 Sep 10]. Available from: https://www.konos.go.kr/konosis/index.jsp.
17 Salizzoni M, Cerutti E, Romagnoli R, Lupo F, Franchello A, Zamboni F, et al. The first one thousand liver transplants in Turin: a single-center experience in Italy. Transpl Int 2005;18:1328-35.   DOI
18 Lee SG. A complete treatment of adult living donor liver transplantation: a review of surgical technique and current challenges to expand indication of patients. Am J Transplant 2015;15:17-38.   DOI
19 Polak WG, Peeters PM, Slooff MJ. The evolution of surgical techniques in clinical liver transplantation. A review. Clin Transplant 2009;23:546-64.   DOI
20 Jain A, Reyes J, Kashyap R, Dodson SF, Demetris AJ, Ruppert K, et al. Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg 2000;232:490-500.   DOI
21 Schoening WN, Buescher N, Rademacher S, Andreou A, Kuehn S, Neuhaus R, et al. Twenty-year longitudinal follow-up after orthotopic liver transplantation: a singlecenter experience of 313 consecutive cases. Am J Transplant 2013;13:2384-94.   DOI
22 Starzl TE, Groth CG, Brettschneider L, Penn I, Fulginiti VA, Moon JB, et al. Orthotopic homotransplantation of the human liver. Ann Surg 1968;168:392-415.   DOI
23 Lee KU, Kim SB, Kim SH, Lee HJ, Suh KS, Kim ST. Liver transplantation in Seoul National University Hospital. Transplant Proc 2002;34:2799-800.   DOI
24 Lee JS, Lee SH, Kim KS, Gil EM, Choi GS, Kim JM, et al. Bacterial infection monitoring in the early period after liver transplantation. Ann Surg Treat Res 2018;94:154-8.   DOI
25 Chan SC, Cheung TT, Chan AC, Chok KS, Sharr WW, Fung JY, et al. New insights after the first 1000 liver transplantations at The University of Hong Kong. Asian J Surg 2016;39:202-10.   DOI